BMC Musculoskelet Disord. May 2016; 17: 226. Authors: Siobhán Stynes, et al Background The identification of clinically relevant subgroups of low back pain (LBP) is considered the number one LBP research priority in primary care. One subgroup of LBP patients are those with back related leg pain. Leg pain frequently accompanies LBP and is associated […]
Read MorePublished in BMC Anesthesiol. 2016;16(11) Authors: I. J. Higginson et al Background: With increasingly intensive treatments and population ageing, more people face complex treatment and care decisions. We explored patterns of the decision-making processes during critical care, and sources of conflict and resolution. Methods: Ethnographic study in two Intensive Care Units (ICUs) in an inner city hospital comprising: […]
Read MoreFor far too many years, pain researchers and clinicians have relied on the concept of the morphine equivalent daily dosage (MEDD), or some variant of it, as a means of comparing the “relative corresponding quantity” of the numerous opioid molecules that are important tools in the treatment of chronic pain. This concept dates back to […]
Read MoreVirtual reality (VR), already shown to have important benefits in the treatment of acute and procedural pain, shows preliminary evidence of also reducing symptoms in chronic pain, according to new research. “Our pain providers desperately need effective nonopioid treatments for chronic pain, ones that patients will adopt and use,” Ted Jones, PhD, from the Behavioral […]
Read MoreA mathematical model developed by researchers at Loyola University in Chicago can predict the length of time patients with hepatitis C virus (HCV) must remain on direct-acting antiviral (DAA) drugs to achieve sustained virologic response, according to a new study. The investigators used early viral kinetic analysis to test study participants—58 people with HCV being […]
Read More